YOLFTbeta
MeVis Medical Solutions AG

MeVis Medical Solutions AG

M3V · XETRA · Healthcare / Health Information Services

20.00EUR+0.10 (+0.50%)

Price History

Full chart

Market Stats

Previous Close19.90
Open19.70
Day Range19.70 – 20.00
52-Week Range21.80 – 25.83
Volume200
Market Cap39.68M
P/E (TTM)51.90
Forward P/E36.90
EPS0.42
Dividend Yield4.36%
Beta-0.03
50-Day Avg23.53
200-Day Avg23.93

About

MeVis Medical Solutions AG develops software for recording, analyzing, and evaluating image data to manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company provides image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, liver, and neurological diseases. It also offers X-ray based radiography procedures, including computed tomography, mammography/digital tomosynthesis, magnetic resonance imaging, and digital sonography; as well as provides services in the field of software programming for medical technology companies, which comprise provision of software developers, product and project managers, application specialists, and test engineers. In addition, the company provides three-dimensional technical visualizations; and interactive online training to enhance the diagnostic skills of clinicians; and internet-based special applications in teleradiology. The company was founded in 1997 and is based in Bremen, Germany. MeVis Medical Solutions AG is a subsidiary of Varex Imaging Corporation.

Company Details

  • SectorHealthcare
  • IndustryHealth Information Services
  • CEOMr. Marcus Kirchhoff
  • Employees127
  • HeadquartersCaroline-Herschel-Str. 1, Bremen, Germany, 28359, Germany
  • Websitehttps://www.mevis.de

Leadership

  • Mr. Marcus KirchhoffChairman of the Executive Board & CEO · b. 1969

Financials

Income Statement

Currency: EUR2006-09-302007-09-302008-09-302009-09-302010-09-302011-09-302012-09-302013-09-302014-09-302015-09-302016-09-302017-09-302018-09-302019-09-302020-09-302021-09-302022-09-302023-09-302024-09-302025-09-30
Total Revenue8.34M7.89M10.84M13.87M14.29M13.68M13.35M14.22M13.09M16.01M16.12M18.54M17.77M18.07M17.13M16.21M18.76M17.34M16.97M16.06M
Growth (%)--5.39%+37.40%+27.90%+3.04%-4.29%-2.42%+6.51%-7.91%+22.33%+0.67%+15.00%-4.13%+1.68%-5.21%-5.35%+15.71%-7.57%-2.13%-5.37%
Cost of Revenue427.00K650.00K367.00K459.00K690.00K712.00K535.00K683.00K634.00K612.00K6.15M506.00K474.00K457.00K626.21K436.85K746.56K10.34M489.67K368.70K
Gross Profit7.92M7.24M10.48M13.41M14.29M12.97M12.81M13.93M12.46M15.40M9.97M18.03M9.18M17.62M16.50M15.78M18.02M7.00M16.48M15.69M
Gross Margin94.88%91.76%96.62%96.69%100.00%94.79%95.99%98.02%95.16%96.18%61.83%97.27%51.65%97.47%96.34%97.31%96.02%40.38%97.11%97.70%
Operating Expense3.44M7.20M9.81M11.78M19.72M14.61M9.84M11.72M9.00M11.08M5.17M10.91M2.49M10.56M8.99M9.33M11.72M558.96K12.48M13.35M
Operating Income4.48M42.00K665.00K1.63M-5.43M-1.64M2.98M2.22M3.45M4.32M4.79M7.12M6.69M7.05M7.51M6.45M6.29M6.44M4.00M2.34M
Operating Margin53.67%0.53%6.13%11.77%-37.97%-12.00%22.29%15.60%26.38%26.98%29.73%38.41%37.66%39.03%43.86%39.79%33.53%37.16%23.58%14.58%
EBITDA5.06M1.07M4.12M5.00M3.97M3.54M4.95M5.91M5.15M6.26M6.31M8.46M8.03M8.41M5.97M4.77M7.97M5.17M4.82M3.43M
EBITDA Margin60.66%13.52%37.98%36.09%27.79%25.85%37.06%41.56%39.33%39.08%39.17%45.64%45.17%46.54%34.87%29.40%42.48%29.83%28.40%21.33%
Net Income2.94M132.00K2.11M398.00K-8.35M-4.09M2.16M3.68M3.71M6.74M4.57M5.62M7.62M8.07M5.70M4.55M7.79M4.92M4.56M3.17M
Net Income Margin35.18%1.67%19.49%2.87%-58.42%-29.92%16.21%25.89%28.36%42.06%28.33%30.32%42.86%44.66%33.30%28.04%41.52%28.37%26.87%19.71%
R&D-------4.28M4.80M3.49M3.45M4.27M3.42M-------
R&D as % of Total Revenue-------30.08%36.65%21.77%21.43%23.03%19.22%-------
Interest Expense330.00K137.00K321.00K996.00K712.00K346.00K346.00K106.00K62.00K22.00K077.00K17.22K9.84K11.73K10.82K3.85K42.82K19.62K577
Interest Expense % of Total Revenue3.96%1.74%2.96%7.18%4.98%2.53%2.59%0.75%0.47%0.14%0.00%0.42%0.10%0.05%0.07%0.07%0.02%0.25%0.12%0.00%

Balance Sheet

Currency: EUR2006-09-302007-09-302008-09-302009-09-302010-09-302011-09-302012-09-302013-09-302014-09-302015-09-302016-09-302017-09-302018-09-302019-09-302020-09-302021-09-302022-09-302023-09-302024-09-302025-09-30
Total Assets9.10M35.58M59.58M50.95M38.78M32.55M30.91M34.37M38.25M45.55M43.00M49.08M38.42M23.92M27.79M27.53M31.20M28.05M26.48M25.89M
Total Liabilities6.45M4.81M26.97M18.35M14.00M11.82M8.15M7.93M7.98M11.82M10.11M16.57M6.36M6.09M9.96M9.71M13.38M10.23M8.66M8.06M
Total Equity2.65M30.77M32.61M32.61M24.79M20.73M22.77M26.45M30.27M33.73M32.89M32.51M17.83M17.83M17.83M17.83M17.83M17.83M17.83M17.83M
Cash5.43M28.47M15.26M7.72M5.62M6.08M8.15M9.89M9.27M25.62M24.36M29.73M3.48M2.60M3.95M7.62M9.32M7.74M6.53M6.52M
Total Debt1.00K154.00K465.00K7.00M-3.97M493.00K328.00K133.00K4.74M-9.37M1.62M-------
Net Debt-5.43M-28.32M-14.79M-719.00K-5.62M-6.08M-7.66M-9.59M-8.98M-20.88M-24.36M-20.37M-1.86M-2.60M-3.95M-7.62M-9.32M-7.74M-6.53M-6.52M

Cash Flow

Currency: EUR2006-09-302007-09-302008-09-302009-09-302010-09-302011-09-302012-09-302013-09-302014-09-302015-09-302016-09-302017-09-302018-09-302019-09-302020-09-302021-09-302022-09-302023-09-302024-09-302025-09-30
Operating Cash Flow4.59M-2.47M2.91M3.07M4.95M5.11M5.29M7.48M4.83M6.58M3.51M7.32M5.52M6.54M2.89M9.13M4.86M5.85M3.15M3.88M
Investing Cash Flow-303.00K-1.64M-13.50M-9.97M-6.54M-4.67M-3.10M-5.56M-5.04M7.91M-179.00K-221.00K-22.43M-5.92M189.04K111.63K58.66K989.98K906.80K945.46K
Financing Cash Flow-888.00K27.15M-2.63M-526.00K-401.00K-39.00K-49.00K-51.00K-9.00K1.63M-4.74M-9.37M-9.37M-1.62M-1.57M-5.70M-4.55M-7.79M-4.92M-4.56M
Capital Expenditure447.00K1.38M1.78M3.04M3.18M2.80M2.60M1.86M1.56M116.00K179.00K221.00K208.00K202.92K102.55K50.86K133.10K79.72K301.91K140.43K
Free Cash Flow4.15M-3.85M1.13M31.00K1.77M2.31M2.69M5.63M3.27M6.46M3.33M7.10M5.31M6.34M2.79M9.08M4.72M5.77M2.84M3.74M
Dividends Paid--------73.00K73.00K4.74M09.37M1.62M1.57M5.70M4.55M7.79M4.92M4.56M
FCF to OCF90.27%155.79%38.93%1.01%35.84%45.21%50.85%75.20%67.71%98.24%94.90%96.98%96.23%96.90%96.45%99.44%97.26%98.64%90.40%96.38%
Dividend Paid to FCF--------2.23%1.13%142.40%0.00%176.32%25.53%56.36%62.82%96.22%134.89%172.95%121.99%

Earnings

Report DateMar 31, 2008Jun 30, 2008Sep 30, 2008Dec 31, 2008Mar 31, 2009Aug 28, 2009Nov 9, 2009May 18, 2010Aug 30, 2010Nov 23, 2010May 30, 2011Aug 30, 2011Nov 21, 2011May 30, 2012Aug 27, 2012Nov 12, 2012May 16, 2013Aug 26, 2013Nov 11, 2013Apr 21, 2014Aug 11, 2014Nov 17, 2014May 21, 2015Aug 11, 2015Nov 19, 2015May 24, 2016Aug 23, 2016Nov 17, 2016Feb 21, 2017May 18, 2017Aug 22, 2017Jan 23, 2018May 15, 2018Aug 21, 2018Jan 29, 2019May 23, 2019Aug 28, 2019Jan 29, 2020May 27, 2020Aug 25, 2020Jan 28, 2021May 27, 2021Aug 24, 2021Jan 27, 2022May 30, 2022Sep 1, 2022Jan 26, 2023May 25, 2023Aug 31, 2023Mar 19, 2024May 27, 2024Sep 4, 2024Nov 27, 2024Jan 30, 2025May 27, 2025Aug 28, 2025
EPS Estimate------------------------------------0.770.00-0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00-0.00
EPS Actual0.370.390.260.440.080.020.07-0.09-0.300.18-0.11-0.570.140.060.32-0.110.470.430.810.400.601.000.370.350.920.180.870.822.40-0.480.230.910.451.511.130.940.770.771.640.001.501.330.001.171.880.002.400.000.000.000.000.000.001.041.320.00
Surprise------------------------------------0.00%-------------------
Timing-------------------------------------------Pre-marketAfter-hours--After-hours-Pre-marketAfter-hoursAfter-hours-Pre-marketPre-market-

Key Statistics & Ratios

Market Cap39.68M
Enterprise Value38.21M
Trailing P/E51.90
Forward P/E36.90
PEG Ratio1.36
Price / Sales2.56
Price / Book2.35
EPS0.42
Book Value9.80
Revenue (TTM)15.48M
Gross Profit (TTM)3.13M
EBITDA801.63K
Profit Margin8.94%
Operating Margin0.22%
Return on Equity7.77%
Return on Assets1.73%
Shares Outstanding1.82M
Shares Float479.39K
Beta-0.03
Dividend Yield4.36%
Dividend Rate0.95
Payout Ratio226.78%

Dividends

20261×
0.95Mar 20, 2026
20251×
0.95Mar 26, 2025
20241×
0.95Mar 20, 2024
20221×
0.95Mar 24, 2022
20211×
0.95Mar 25, 2021
20201×
0.95Jun 25, 2020
20191×
0.95Mar 22, 2019
20181×
0.95Mar 15, 2018
20171×
0.71Mar 9, 2017
20161×
0.95Jun 8, 2016
20151×
0.04Jun 10, 2015